Hemolytic disease of the newborn

Skip Navigation

Hemolytic disease of the newborn (also called erythroblastosis fetalis) is a serious condition that may occur when the blood types of you and your baby do not match. Substances (antibodies) in your blood cross the placenta and may destroy the red blood cells of the fetus.

After birth, a baby with hemolytic disease may be treated with a blood transfusion.

The Health Encyclopedia contains general health information. Not all treatments or services described are covered benefits for Kaiser Permanente members or offered as services by Kaiser Permanente. For a list of covered benefits, please refer to your Evidence of Coverage or Summary Plan Description. For recommended treatments, please consult with your health care provider.